Unum Therapeutics Inc

UMRX 2.28
0.03 (1.3%)

Open: 2.31 High: 2.38 Low: 2.20

9 x 2.28 = 20.52
x $2.28 =

NASDAQ: UMRX $110 Million Small-Cap. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 78%. 1 Year Return 44%. 2020 YTD Return 247%. Since Earnings 443%.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $0.30

The 52 Week Low is $0.30 set on Fri, Apr 3, 2020.

52WH $3.72

The 52 Week High is $3.72 set on Fri, Jul 10, 2020.

ATH $17.53

The All-Time High is $17.53 set on Tue, Jul 31, 2018.

52 Week Range

$0.30
$3.72
Apr 3, 2020
Jul 10, 2020

Earnings

-0.24

Earnings Per Share

0.00

Price To Earnings Ratio


Q4 Earnings for Oct, Nov & Dec

Thu, Mar 26, 2020

Since Q4 Earnings Report

UMRX 365.3%


Q1 Earnings for Jan, Feb & Mar

Mon, May 11, 2020

Since Q1 Earnings Report

UMRX 395.7%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Unum Therapeutics Inc trades on the NASDAQ. UMRX's market cap is 110.00 Million.

Unum Therapeutics Inc is an US based clinical-stage biopharmaceutical company. it is focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer.

Website

Related Channels

Account Channels

Track your portfolio and more.